Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · IEX Real-Time Price · USD
0.835
-0.012 (-1.39%)
At close: Jul 19, 2024, 4:00 PM
0.760
-0.075 (-9.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Achilles Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ACHL stock have an average target of 2.83, with a low estimate of 0.50 and a high estimate of 6.00. The average target predicts an increase of 238.84% from the current stock price of 0.84.
Analyst Consensus: Hold
* Price targets were last updated on Apr 5, 2024.
Analyst Ratings
The average analyst rating for ACHL stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 1 | 1 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $8 → $2 | Buy → Hold | Downgrades | $8 → $2 | +139.46% | Apr 5, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $6 | Strong Buy | Maintains | $11 → $6 | +618.39% | Apr 5, 2024 |
B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $0.5 | Strong Buy → Sell | Downgrades | $7 → $0.5 | -40.13% | Dec 14, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,217.05% | Aug 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +1,217.05% | May 11, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.99
from -1.74
EPS Next Year
-1.13
from -0.99
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | n/a | n/a |
Avg | n/a | n/a | n/a | n/a | n/a |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.20 | -0.13 | -2.88 | -3.38 | -3.96 |
Avg | -0.99 | -1.13 | -2.79 | -3.28 | -3.85 |
Low | -1.72 | -2.05 | -2.69 | -3.16 | -3.69 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.